[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100643016":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":29,"centralContacts":36,"locations":42,"responsibleParty":61,"collaborators":29,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":29,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":29,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":88,"whyStopped":29,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Fudan University","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"propofol group","EXPERIMENTAL","All patients in this arm receive Propofol at a concentration of 10 mg\u002FmL, administered via infusion at a dose of 1 mg\u002Fkg and completed within 5 minutes.",[13],"Drug: propofol",{"label":15,"type":10,"description":16,"interventionNames":17},"Dexmedetomidine group","All subjects in this arm receive Dexmedetomidine with a prepared concentration of 10 μg\u002FmL. A loading dose of 1.0 μg\u002Fkg is administered by infusion and completed within 10 minutes.",[18],"Drug: Dexmeditomidine",{"label":20,"type":10,"description":21,"interventionNames":22},"Esketamine group","All subjects in this arm are given Esketamine at a prepared concentration of 5 mg\u002FmL, infused at a dose of 0.5 mg\u002Fkg and completed within 10 minutes.",[23],"Drug: Esketamine",[25,30,33],{"type":26,"name":27,"description":11,"armGroupLabels":28,"otherNames":29},"DRUG","propofol",[9],null,{"type":26,"name":31,"description":16,"armGroupLabels":32,"otherNames":29},"Dexmeditomidine",[15],{"type":26,"name":34,"description":21,"armGroupLabels":35,"otherNames":29},"Esketamine",[20],[37],{"name":38,"role":39,"phone":40,"phoneExt":29,"email":41},"Xiaoge Liu","CONTACT","021-64175590","18516534948@163.com",[43],{"facility":44,"status":29,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Fudan University Shanghai Cancer Center","Shanghai","Shanghai Municipality","200032","China","CN",{"type":51,"coordinates":52},"Point",[53,54],121.45806,31.22222,{"lat":54,"lon":53},[57],{"name":58,"role":39,"phone":59,"phoneExt":29,"email":60},"Jun Zhang","+86 13817153025","snapzhang@aliyun.com",{"type":62,"investigatorFullName":58,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"PRINCIPAL_INVESTIGATOR","Director of Anesthesiology Department, Fudan University Shanghai Cancer Center","100643016","phase-4-the-effects-of-different-anesthetics-on-the-brains-neural-networks-100643016",false,"NCT07644663","The Effects of Different Anesthetics on the Brain's Neural Networks","Propofol, Dexmedetomidine, and Esketamine-Induced Unresponsive States: Alterations in Information Integration and Brain Networks","Inclusion Criteria:\n\n* Patients scheduled for elective non-cardiac surgery;\n* American Society of Anesthesiologists (ASA) physical status classification I-II;\n* Aged 18 to 65 years, regardless of gender;\n* Body mass index (BMI) greater than 18 kg\u002Fm² and no more than 31 kg\u002Fm²;\n* Written informed consent voluntarily signed by the patient or legal authorized representative for participation in this study.\n\nExclusion Criteria:\n\nSubjects meeting any one of the following items will be excluded from this study:\n\n* Presence of severe cardiovascular diseases or hepatic and renal insufficiency;\n* Hearing impairment;\n* History of psychiatric disorders or communication disorders;\n* Anticipated difficult airway;\n* Pregnant or lactating women;\n* History of allergic reaction or contraindication to any of the three anesthetic drugs used in this trial;\n* Participation in other clinical trials within the past 3 months.","ALL","18 Years","65 Years",{"count":75,"type":76},120,"ESTIMATED","INTERVENTIONAL",[79],"PHASE4","This study aims to analyze the electroencephalographic power spectrum and connectivity during unresponsive states induced by propofol, esketamine and dexmedetomidine, respectively. It intends to explore the macro neural mechanisms underlying anesthetic unresponsiveness, so as to further elucidate the mechanisms by which anesthetics induce loss and recovery of consciousness. In addition, this study will identify neural biomarkers under general anesthesia for monitoring patients' actual intraoperative consciousness status. The findings will facilitate the development of monitoring indicators and devices reflecting intraoperative consciousness during general anesthesia, enabling more accurate assessment of patients' intraoperative consciousness status.",[82,83],"Electroencephalogram (EEG)","Anesthesia",[85,86,87],"EEG","anesthesia","loss of responsiveness","NOT_YET_RECRUITING","2026-06-08",{"date":91,"type":92},"2026-06-12","ACTUAL",{"date":94,"type":76},"2026-06-09",{"date":96,"type":76},"2026-09-10",{"name":5,"class":6},1]